Frontiers in Bioengineering and Biotechnology,
Journal Year:
2023,
Volume and Issue:
11
Published: April 14, 2023
This
is
a
mini
review
on
the
biotechnological
aspects
of
most
extensively
developed
hemoglobin-based
oxygen
carriers
The
emphasis
recent
Polyhemoglobin-catalase-superoxide
dismutase-carbonic
anhydrase
(PolyHb-CAT-SOD-CA),
which
nanobiotechnological
complex
that
being
investigated
and
scaled
up
with
potential
for
clinical
use
as
nanobiotherapeutics.
Hemoglobin,
tetramer,
an
excellent
carrier.
However,
in
body
it
converted
into
toxic
dimers.
Diacid
or
glutaraldehyde
can
crosslink
hemoglobin
polyhemoglobin
(PolyHb)
prevent
its
breakdown
has
been
tested
trials.
A
bovine
approved
routine
surgical
procedures
South
Africa
Russia.
Clinical
trials
human
PolyHb
hemorrhagic
shock
were
effective
but
very
slight
increase
non-fatal
myocardial
ischemia.
could
be
due
to
number
reasons.
For
those
conditions
ischemia-reperfusion,
one
would
need
carrier
antioxidant
properties.
One
approach
remedy
this
prepared
polyhemoglobin-catalase-superoxide
dismutase
(PolyHb-CAT-SOD).
Another
reason
intracellular
pCO
2
.
We
therefore
added
enhanced
level
carbonic
prepare
PolyHb-CAT-SOD-CA.
result
Carbonic
Anhydrase
CO
transport
Catalase
Superoxide
Dismutase
functions.
Detailed
efficacy
safety
studies
have
led
industrial
scale
towards
trial.
In
meantime,
are
around
world
ex
vivo
fluid
organ
preservation
transplantation,
already
France.
Cell Reports Medicine,
Journal Year:
2024,
Volume and Issue:
5(1), P. 101373 - 101373
Published: Jan. 1, 2024
Myalgic
encephalomyelitis/chronic
fatigue
syndrome
(ME/CFS)
is
a
serious
and
poorly
understood
disease.
To
understand
immune
dysregulation
in
ME/CFS,
we
use
single-cell
RNA
sequencing
(scRNA-seq)
to
examine
cells
patient
control
cohorts.
Postexertional
malaise
(PEM),
an
exacerbation
of
symptoms
following
strenuous
exercise,
characteristic
symptom
ME/CFS.
detect
changes
coincident
with
PEM,
applied
scRNA-seq
on
the
same
cohorts
exercise.
At
baseline,
ME/CFS
patients
display
classical
monocyte
suggestive
inappropriate
differentiation
migration
tissue.
We
identify
both
diseased
more
normal
monocytes
within
patients,
fraction
correlates
disease
severity.
Comparing
transcriptome
at
baseline
postexercise
challenge,
discover
patterns
indicative
improper
platelet
activation
minimal
elsewhere
system.
Taken
together,
these
data
immunological
defects
present
additional
layer
platelets.
Circulation,
Journal Year:
2024,
Volume and Issue:
150(7)
Published: June 27, 2024
This
scientific
statement
presents
a
conceptual
framework
for
the
pathophysiology
of
post–cardiac
arrest
brain
injury,
explores
reasons
previous
failure
to
translate
preclinical
data
clinical
practice,
and
outlines
potential
paths
forward.
Post–cardiac
injury
is
characterized
by
4
distinct
but
overlapping
phases:
ischemic
depolarization,
reperfusion
repolarization,
dysregulation,
recovery
repair.
Previous
research
has
been
challenging
because
limitations
laboratory
models;
heterogeneity
in
patient
populations
enrolled;
overoptimistic
estimation
treatment
effects
leading
suboptimal
sample
sizes;
timing
route
intervention
delivery;
limited
or
absent
evidence
that
engaged
mechanistic
target;
postresuscitation
care,
prognostication,
withdrawal
life-sustaining
treatments.
Future
trials
must
tailor
their
interventions
subset
patients
most
likely
benefit
deliver
this
at
appropriate
time,
through
route,
dose.
The
complexity
suggests
monotherapies
are
unlikely
be
as
successful
multimodal
neuroprotective
therapies.
Biomarkers
should
developed
identify
with
targeted
mechanism
quantify
its
severity,
measure
response
therapy.
Studies
need
adequately
powered
detect
effect
sizes
realistic
meaningful
patients,
families,
clinicians.
Study
designs
optimized
accelerate
evaluation
promising
interventions.
Multidisciplinary
international
collaboration
will
essential
realize
goal
developing
effective
therapies
injury.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 13, 2024
Abstract
The
growing
disparity
between
the
demand
for
transplants
and
available
donor
supply,
coupled
with
an
aging
population
increasing
prevalence
of
chronic
diseases,
highlights
urgent
need
development
platforms
enabling
reconditioning,
repair,
regeneration
deceased
organs.
This
necessitates
ability
to
preserve
metabolically
active
kidneys
ex
vivo
days.
However,
current
kidney
normothermic
machine
perfusion
(NMP)
approaches
allow
metabolic
preservation
only
hours.
Here
we
show
that
human
discarded
transplantation
can
be
preserved
in
a
state
up
4
days
when
perfused
cell-free
perfusate
supplemented
TCA
cycle
intermediates
at
subnormothermia
(25
°C).
Using
spatially
resolved
isotope
tracing
demonstrate
fluxes
microenvironment
Day
perfusion.
Beyond
4,
significant
changes
were
observed
renal
cell
populations
through
spatial
lipidomics,
increases
injury
markers
such
as
LDH,
NGAL
oxidized
lipids.
Finally,
maintain
functional
parameters
4.
Collectively,
these
findings
provide
evidence
this
approach
enables
over
multiple
days,
establishing
solid
foundation
future
clinical
investigations.
Med,
Journal Year:
2024,
Volume and Issue:
5(8), P. 1016 - 1029.e4
Published: May 21, 2024
Xenotransplantation
of
genetically
engineered
porcine
organs
has
the
potential
to
address
challenge
organ
donor
shortage.
Two
cases
porcine-to-human
kidney
xenotransplantation
were
performed,
yet
physiological
effects
on
xenografts
and
recipients'
immune
responses
remain
largely
uncharacterized.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(8), P. 4153 - 4153
Published: April 9, 2024
Heart
transplantation
with
donation
after
circulatory
death
(DCD)
provides
excellent
patient
outcomes
and
increases
donor
heart
availability.
However,
unlike
conventional
grafts
obtained
through
brain
death,
DCD
cardiac
are
not
only
exposed
to
warm,
unprotected
ischemia,
but
also
a
potentially
damaging
pre-ischemic
phase
withdrawal
of
life-sustaining
therapy
(WLST).
In
this
review,
we
aim
bring
together
knowledge
about
changes
in
energy
metabolism
its
regulation
that
occur
donors
during
WLST,
arrest,
following
the
onset
warm
ischemia.
Acute
metabolic,
hemodynamic,
biochemical
expose
hearts
high
circulating
catecholamines,
hypoxia,
all
which
can
negatively
impact
heart.
Further
metabolic
cellular
damage
reperfusion.
The
altered
substrate
availability
prior
organ
procurement
likely
plays
an
important
role
graft
quality
post-ischemic
recovery.
These
aspects
should,
therefore,
be
considered
clinical
protocols,
as
well
pre-clinical
models.
Notably,
interventions
limited
for
ethical
reasons
donors;
thus,
it
is
understand
these
mechanisms
optimize
conditions
initial
reperfusion
concert
evaluation
re-evaluation
purpose
tailoring
adjusting
therapies
ensuring
optimal
transplantation.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Abstract
Accurate
analysis
of
cell
atlas
and
gene
expression
in
biological
tissues
using
single-nucleus
RNA
sequencing
(snRNA-seq)
is
dependent
on
the
quality
source
material,
post-mortem
interval
(PMI)
one
major
sources
variation
quality.
Although
use
RNA-degraded
transcriptome
remains
controversial,
such
samples
are
sometimes
sole
means
to
address
specific
questions.
Current
studies
impact
PMI
data
limited
large-scale
RNA-seq,
which
ignores
cellular
heterogeneity.
Thus,
deciphering
non-cell-
autonomous
effects
caused
by
imperative
for
understanding
molecular
disruption
it
elicits.
Here,
we
investigated
components
snRNA-seq
from
mouse
brain
post-mortem.
We
collected
that
were
allowed
decay
varying
amounts
time
at
25°C
prior
snRNA-seq,
covering
entire
range
RIN
values.
The
different
degradation
rate
mRNA
rRNA
within
nuclei,
presented
a
more
stable
state.
Multi-channel
revealed
preferential
transient
depletion
oligodendrocytes
OPCs
with
increasing
PMI.
In
addition,
rapid
widespread
overregulation
ribosomal
recruitment
protein
(RP)
genes
various
cells,
reached
plateau
36h.
state
neuronal
cells
was
not
detected,
reported
significant
upregulation
PMI-dependent
RP
its
subpopulations
their
loss.
Moreover,
showed
greatest
differential
greater
perturbation,
speculated
aberrant
these
might
be
associated
death.
this
study,
systematically
changes
profile
tissue
induced
single-cell
resolution,
important
factors
responsible
changes.
our
complemented
possible
explanation
postmortem
hypoxia-ischemia,
provided
reference
samples.
European Heart Journal Supplements,
Journal Year:
2025,
Volume and Issue:
27(Supplement_4), P. iv31 - iv38
Published: Feb. 4, 2025
Abstract
Cardiac
arrest
is
a
critical
emergency
in
cardiovascular
medicine,
requiring
rapid,
multidisciplinary
interventions
to
enhance
patient
survival
and
neurological
outcomes.
This
review
explores
the
unique
challenges
of
managing
out-of-hospital
(OHCA)
in-hospital
cardiac
(IHCA),
with
focus
on
mechanical
circulatory
support
(MCS)
extracorporeal
cardiopulmonary
resuscitation
for
selected
patients.
While
OHCA
management
should
prioritize
rapid
transport
specialized
centres,
IHCA
may
allow
immediate,
patient-tailored
interventions.
Post-cardiac
syndrome
adds
complexity,
often
nuanced
MCS
escalation
weaning.
Standardized
protocols,
ethical
considerations,
further
research
are
essential
refine
selection
improve
outcomes,
ultimately
advancing
care.
Clinical Transplantation,
Journal Year:
2025,
Volume and Issue:
39(2)
Published: Feb. 1, 2025
The
demand
for
organ
transplantation
has
exceeded
the
global
supply
of
available
organs.
Donation
after
circulatory
death
(DCD)
is
considered
an
effective
method
to
solve
disparity
between
and
organs,
by
expanding
donor
pool.
However,
DCD
organs
experience
long-term
damage
caused
warm
ischemia
(WI)
microthrombosis
diffuse
intravascular
coagulation.
Unfortunately,
because
concerns
about
post-transplantation
complications,
most
high-risk
are
discarded,
resulting
in
wasted
medical
resources
economic
losses.
thrombolytic
therapy
before
may
dissolve
improve
microcirculation,
increase
use.
Herein,
we
review
current
status
potential
value
transplantation,
summarize
progress
according
preclinical
clinical
research,
emphasize
heterogeneity
limitations
studies
that
have
some
controversies
associated
with
this
therapy.
Overall,
role
should
not
be
overlooked.
We
anticipate
combined
machine
perfusion
will
provide
opportunity
inferior-quality
grafts,
their
becoming
more
widely
safer
thus
solving
urgent
problem
shortage.